Sorbitol Is a Severity Biomarker for <scp>PMM2‐CDG</scp> with Therapeutic ImplicationsAnna N. Ligezka, Éva Morava, William Brucker et al.|Annals of Neurology|2021Cited by 57
Coagulation abnormalities in a prospective cohort of 50 patients with PMM2-congenital disorder of glycosylationDiederik De Graef, Éva Morava, Anna N. Ligezka et al.|Molecular Genetics and Metabolism|2023Cited by 16
Epicatechin acts synergistically with curcumin-induced cytogenotoxic effect in acute promyelocytic leukemia HL-60 cell lineMonika Papież, Wirginia Krzyściak|Journal of Unexplored Medical Data|2017Cited by 3
Coagulation Abnormalities in a Prospective Cohort of 50 Patients with PMM2-Congenital Disorder of GlycosylationDiederik De Graef, Éva Morava, Anna N. Ligezka et al.|SSRN Electronic Journal|2023Cited by 0